MedTrace Logo

The Safety, Acceptability and Efficacy of Alena

NCT05858294 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2023-05-15

No results posted yet for this study

Summary

The present study is a randomised controlled trial that seeks to investigate the safety, acceptability and efficacy and safety of the Alena CBT programme as a treatment for social anxiety disorder.

Conditions

Interventions

BEHAVIORAL

Cognitive Behavioral Therapy programme

This mobile application comprised CBT-based therapy for social anxiety based on the Clark and Wells model

Sponsors & Collaborators

  • Aya Technologies Limited

    lead INDUSTRY

Principal Investigators

  • Mandana Ahmadi, PhD · Aya Technologies Limited

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-31
Primary Completion
2022-12-04
Completion
2022-12-18

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05858294 on ClinicalTrials.gov